$TJX

Klinger John sold $1.0M of TJX

Klinger John (SEVP, CFO) sold 6,235 shares of TJX COMPANIES INC /DE/ (TJX) at $160.77 ($1.00M total) on 2026-06-05.

Original reporting
SEC EDGAR · Klinger John
Published Jun 5, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TJX
Neutral
high confidence
Mentioned
$TJX
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TJXNeutralLow
01

Why it matters

Insider sale disclosures are typically low-signal unless paired with other negative events (earnings miss, guidance cut, investigations). Here, only the transaction details are provided.

02

Market read

A same-day insider sale at TJX is disclosed; traders may note it for sentiment/positioning, but it is not a fundamental catalyst.

03

What to watch

The filing does not state a 10b5-1 plan; without context (taxes, planned diversification), interpreting directionality is unreliable.

Relevance 6/10Novelty 4/10Timing: Filed same day (2026-06-05) as the insider sale disclosure.

Background

The article is an SEC Form 4 insider transaction disclosure for TJX, reporting an open-market sale by the CFO.

Company-level read

Ticker impact

$TJXNeutralHigh confidence
Context

TJX CFO sold 6,235 shares in an open-market transaction disclosed via SEC Form 4 at ~$160.77/share.

Expected impact

Likely minimal near-term impact; any effect is more about positioning/interpretation than new information.

Evidence & confidence

This is a routine insider transaction with no 10b5-1 plan disclosed and no accompanying operational or financial catalyst.

Market effects

No direct sector read-through; insider selling at a single retailer is not a sector catalyst.

None indicated.

None indicated.

Counterpoint

Officer sales can reflect diversification or liquidity needs rather than bearish views, especially absent any other negative catalyst.

Key entities

  • TJX COMPANIES INC /DE/

    Issuer of the SEC Form 4 insider transaction; CFO sold shares on 2026-06-05.

  • Klinger John

    TJX SEVP/CFO who executed the open-market sale disclosed in the filing.

Related articles

$POWLMed

The Great Rotation: 5 Stocks Set to Win as Money Leaves Megacap Tech

The article says money is rotating out of megacap tech and into financials and energy, citing Nasdaq-100 down 3.28% over a month while the Russell 2000 rose 1.2%. It highlights JPMorgan’s Q2 2026 EPS $7.70 vs $5.80 and $57.35B revenue vs $51.30B, TJX’s Q1 FY27 EPS $1.19 vs $1.00, Devon’s Coterra merger and DVN dividend hike, and Robinhood’s Q1 2026 deposit and Gold subscriber growth.

$BURLMedAI 9/10

Burlington Beat Earnings Estimates, But Not Investor Expectations

Burlington Stores reported a quarter that cleared Wall Street estimates, but shares fell nearly 8% to around $300 before partially recovering. Management said higher oil prices and Middle East conflict affect its outlook, and it’s more cautious than in March due to higher gas prices and inflation risk. Analysts’ average 12-month target is about $357; consensus is Moderate Buy.